TLTFF - Theralase Technologies Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Theralase Technologies Inc.

41 Hollinger Road
Toronto, ON M4B 3G4
Canada
416-699-5273
http://www.theralase.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. Kristina HacheyCFO & DirectorN/AN/AN/A
Dr. Arkady MandelChief Scientific Officer & DirectorN/AN/AN/A
Mr. Roger John Dumoulin-WhiteDirector of Bus. Devel.N/AN/AN/A
Dr. Shawn Shirazi Ph.D.Chief Exec. OfficerN/AN/AN/A
Mr. David M. Groves B.APres of World Trade DivisionN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Anti-Cancer Therapy and Medical Laser Technology. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1995 and is headquartered in Toronto, Canada.

Corporate Governance

Theralase Technologies Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.